FDA PUBLIC MEETING STATEMENT, OPINION AND RECOMMENDATION Development and Regulation of Abuse-Deterrent Formulations of Opioid Medications; Public Meeting The meeting will focus on scientific and technical issues related - ethers - Document - PDFSEARCH.IO

First Page	Meta Content
	FDA PUBLIC MEETING STATEMENT, OPINION AND RECOMMENDATION Development and Regulation of Abuse-Deterrent Formulations of Opioid Medications; Public Meeting The meeting will focus on scientific and technical issues related Add to Reading List Document Date: 2014-10-31 11:35:19 Open Document File Size: 91,36 KB Share Result on Facebook IndustryTerm healthcare / abuse-deterrent technology / law enforcement / / MedicalCondition pain / chronic disease / chronic pain / / Organization Marmaras Manager / State and National Advocacy Global Healthy Living Foundation / FDA / Global Healthy Living Foundation / / Person Stephen Marmaras / / Position advocate for themselves / Speaker / manager of state and national advocacy / Governor / Attorneys General / / Technology abuse-deterrent technology / / SocialTag Alcohols Morphinans Ethers Euphoriants Opioid Morphine Food and Drug Administration Chemistry Organic chemistry Phenols

FDA PUBLIC MEETING STATEMENT, OPINION AND RECOMMENDATION Development and Regulation of Abuse-Deterrent Formulations of Opioid Medications; Public Meeting The meeting will focus on scientific and technical issues related Add to Reading List